3 most recent filings and news items mentioning IMUX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/IMUX/news?limit=20"
Pull IMUX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayImmunic announced presentation of three posters at the CMSC Annual Meeting showcasing additional Phase 2 CALLIPER trial data for vidofludimus calcium in progressive multiple sclerosis, including a late-breaking analysis introducing novel statistical methods for measuring disabili
View filing at SEC.gov →IMMUNIC, INC. has entered into an employment agreement with Erik Lundgren to serve as CEO effective May 22, 2026. The appointment represents a leadership change for the biopharmaceutical company.
View filing at SEC.gov →Immunic appointed biopharmaceutical veteran Michael Bonney as Chair of the Board, effective May 16, 2026, replacing interim chair Simona Skerjanec who remains as director. Bonney brings 30+ years of industry experience including leadership at Biogen during Avonex's MS launch and
View filing at SEC.gov →